Showing results (951-960 of 1,000) with videos related to
Sort By:
Pageof 100
Nature Communications|July 28, 2016
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityElad Jacoby, Sang M Nguyen, Thomas J Fountaine, et al.European Heart Journal|December 8, 2019
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54Remo H M Furtado, Jose C Nicolau, Giulia Magnani, et al.Journal of the American College of Cardiology|September 9, 2017
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54Marc P Bonaca, Robert F Storey, Pierre Theroux, et al.Journal of Molecular and Cellular Cardiology|February 8, 2024
The alpha-1A adrenergic receptor regulates mitochondrial oxidative metabolism in the mouse heartPeyton B Sandroni, Melissa A Schroder, Hunter T Hawkins, et al.European Heart Journal|October 8, 2015
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trialGiulia Magnani, Robert F Storey, Gabriel Steg, et al.Cancer Immunology Research|May 17, 2022
Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult SubjectsFrancesco Ceppi, Ashley L Wilson, Colleen Annesley, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2018
Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic MiceChristopher A Pennell, Jessie L Barnum, Cameron S McDonald-Hyman, et al.Journal of the American College of Cardiology|April 6, 2016
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery DiseaseMarc P Bonaca, Deepak L Bhatt, Robert F Storey, et al.European Heart Journal|October 23, 2015
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54Marc P Bonaca, Deepak L Bhatt, P Gabriel Steg, et al.The New England Journal of Medicine|December 29, 2016
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell TherapyChristine E Brown, Darya Alizadeh, Renate Starr, et al.Pageof 100